Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$596M |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$429M |
| 3 |
Verizon
VZ
|
+$399M |
| 4 |
Amgen
AMGN
|
+$214M |
| 5 |
Citizens Financial Group
CFG
|
+$212M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MBS ETF
MBB
|
+$561M |
| 2 |
iShares National Muni Bond ETF
MUB
|
+$535M |
| 3 |
Oracle
ORCL
|
+$144M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$143M |
| 5 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$141M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.17% |
| 2 | Financials | 13.07% |
| 3 | Healthcare | 12.05% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Industrials | 9.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2726
United States Lime & Minerals
USLM
$3.17B
| $1.93M | ﹤0.01% |
69,215
+300
| +0.4% | +$8.44K |
|
2727
Powell Industries
POWL
$7.76B
| $1.92M | ﹤0.01% |
186,060
+9,795
| +6% | +$113K |
|
2728
Scholar Rock
SRRK
$5.66B
| $1.92M | ﹤0.01% |
66,434
+4,100
| +7% | +$125K |
|
|
OCFT
2729
DELISTED
OneConnect Financial Technology
OCFT
| $1.92M | ﹤0.01% |
15,963
+9,076
| +132% | +$1.3M |
|
|
IVC
2730
DELISTED
Invacare Corporation
IVC
| $1.92M | ﹤0.01% |
237,420
+10,274
| +5% | +$85.6K |
|
2731
Amalgamated Financial
AMAL
$1.47B
| $1.91M | ﹤0.01% |
122,453
| – | – |
|
2732
Limoneira
LMNR
$235M
| $1.91M | ﹤0.01% |
108,748
+6,249
| +6% | +$114K |
|
|
AXDX
2733
DELISTED
Accelerate Diagnostics
AXDX
| $1.91M | ﹤0.01% |
23,635
+3,335
| +16% | +$265K |
|
2734
VirnetX Holding Corp
VHC
$54.6M
| $1.9M | ﹤0.01% |
22,222
+407
| +2% | +$38.2K |
|
2735
Aclaris Therapeutics
ACRS
$715M
| $1.89M | ﹤0.01% |
107,838
+92,049
| +583% | +$2.09M |
|
2736
Park-Ohio Holdings
PKOH
$582M
| $1.89M | ﹤0.01% |
58,778
+592
| +1% | +$20.8K |
|
2737
MINISO
MNSO
$3.88B
| $1.87M | ﹤0.01% |
+90,059
| New | +$2.16M |
|
|
BVH
2738
DELISTED
Bluegreen Vacations Holding Corporation
BVH
| $1.87M | ﹤0.01% |
104,052
+18,295
| +21% | +$359K |
|
2739
Rush Enterprises Class B
RUSHB
$6.1B
| $1.87M | ﹤0.01% |
73,509
+456
| +0.6% | +$13.1K |
|
2740
Atossa Therapeutics
ATOS
$21.5M
| $1.86M | ﹤0.01% |
19,597
+17,776
| +976% | +$941K |
|
|
CSLT
2741
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $1.86M | ﹤0.01% |
706,198
+259,277
| +58% | +$483K |
|
2742
908 Devices
MASS
$318M
| $1.85M | ﹤0.01% |
47,850
+1,666
| +4% | +$75.5K |
|
2743
Rigel Pharmaceuticals
RIGL
$680M
| $1.85M | ﹤0.01% |
42,731
-360
| -0.8% | -$13.6K |
|
|
ASXC
2744
DELISTED
Asensus Surgical, Inc.
ASXC
| $1.85M | ﹤0.01% |
584,267
+533,025
| +1,040% | +$1.33M |
|
2745
Taysha Gene Therapies
TSHA
$1.66B
| $1.85M | ﹤0.01% |
87,030
+28,787
| +49% | +$664K |
|
|
RXDX
2746
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $1.85M | ﹤0.01% |
+75,128
| New | +$1.68M |
|
2747
Sea Limited
SE
$65.6B
| $1.84M | ﹤0.01% |
+6,710
| New | +$1.7M |
|
|
XOG
2748
DELISTED
Extraction Oil & Gas, Inc. Common Stock
XOG
| $1.82M | ﹤0.01% |
+33,137
| New | +$1.57M |
|
2749
Aligos Therapeutics
ALGS
$26M
| $1.82M | ﹤0.01% |
3,562
+698
| +24% | +$445K |
|
2750
Energy Fuels
UUUU
$2.86B
| $1.81M | ﹤0.01% |
299,309
+15,472
| +5% | +$94.9K |
|
Similar funds
Charles Schwab's Q2 2021 Portfolio in Review
As of Q2 2021, Charles Schwab held 3,648 positions worth $301B, up 10% from $273B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q2 2021 filing shows 163 new, 2,481 increased, 676 reduced and 240 closed positions. Its largest new stake was Vanguard Intermediate-Term Treasury ETF: 6,338,757 shares worth $430M. The largest sale was iShares MBS ETF, an estimated $561M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q2 2021 buy was Vanguard Intermediate-Term Treasury ETF: 6,338,757 shares worth $430M.
- Charles Schwab added most to iShares 1-5 Year Investment Grade Corporate Bond ETF in Q2 2021, an estimated $596M increase.
- Charles Schwab's biggest Q2 2021 reduction was iShares MBS ETF, cutting an estimated $561M.
- Charles Schwab fully exited Invesco S&P 500 Low Volatility ETF in Q2 2021, selling an estimated $92.7M.
- Charles Schwab's ten largest holdings make up 17% of its $301B portfolio in Q2 2021.
- Charles Schwab opened 163 new positions and closed 240 in Q2 2021.
- Charles Schwab's portfolio value rose 10% quarter-over-quarter to $301B.
Based on Charles Schwab's 13F filing for Q2 2021, filed 16 Aug 2021.